Care pathway of patients with metastatic pancreatic cancer in daily practice in France: Results from the REPERE national survey. En savoir plus sur Care pathway of patients with metastatic pancreatic cancer in daily practice in France: Results from the REPERE national survey.
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX. En savoir plus sur Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.